Drug profile · INN
atrasentan hydrochloride
VANRAFIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
atrasentan hydrochloride (VANRAFIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN atrasentan hydrochloride
Brand VANRAFIA
Route ORAL
Formulation TABLET
Frequently asked questions
What is atrasentan hydrochloride?
atrasentan hydrochloride (VANRAFIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for atrasentan hydrochloride?
VANRAFIA is a marketed brand name for atrasentan hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of atrasentan hydrochloride?
atrasentan hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.